Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.44 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | SRC | P12931 | 1/20 | 0.44 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.42 |
| ▸ | MEN1 | O00255 | 4/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | GRM8 | O00222 | 1/20 | 0.41 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.41 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.40 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.40 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28513 | 1.00 | TDP1 (0.44) | TDP1NR1I2PTGS1ADRA1ALMNA | |
| Hydrochloric Acid SCHEMBL28838130 | 0.98 | TDP1 (0.43) | TDP1NR1I2PTGS1ADRA1ALMNA | |
| SCHEMBL6807352 | 0.83 | CYP2D6 (0.48) | LMNASRCCYP2D6SLC1A3SLC1A2 | |
| SCHEMBL14935796 | 0.83 | CYP2D6 (0.48) | LMNASRCCYP2D6SLC1A3SLC1A2 | |
| SCHEMBL6947260 | 0.83 | CYP2D6 (0.48) | LMNASRCCYP2D6SLC1A3SLC1A2 | |
| Hydrochloric Acid SCHEMBL8695663 | 0.82 | CYP2D6 (0.46) | LMNASRCCYP2D6SLC1A3SLC1A2 | |
| Methane SCHEMBL4340079 | 0.82 | CYP2D6 (0.46) | LMNASRCCYP2D6SLC1A3SLC1A2 | |
| SCHEMBL22074716 | 0.79 | TDP1 (0.67) | TDP1NR1I2PTGS1ADRA1ALMNA | |
| SCHEMBL304041 | 0.79 | TDP1 (0.47) | TDP1NR1I2PTGS1ADRA1ALMNA | |
| SCHEMBL16826249 | 0.79 | TDP1 (0.47) | TDP1NR1I2PTGS1ADRA1ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230331779-A1 | BISPECIFIC FUSION POLYPEPTIDE COMPOUND | SHAANXI MICOT TECHNOLOGY CO., LTD. (CN) | 2023-10-19 | — | — | US | claimed |
| EP-4212542-A1 | BISPECIFIC FUSION POLYPEPTIDE COMPOUND | Shaanxi Micot Technology Limited Company (CN) | 2023-07-19 | — | — | EP | claimed |
| CN-115087662-A | Bispecific fusion polypeptide compounds | 陕西麦科奥特科技有限公司 | 2022-09-20 | — | — | CN | claimed |
| WO-2022052471-A1 | BISPECIFIC FUSION POLYPEPTIDE COMPOUND | 陕西麦科奥特科技有限公司 | 2022-03-17 | — | — | WO | claimed |
| US-20230331779-A1 | BISPECIFIC FUSION POLYPEPTIDE COMPOUND | SHAANXI MICOT TECHNOLOGY CO., LTD. (CN) | 2023-10-19 | — | — | US | disclosed |
| CN-115087662-B | Bispecific fusion polypeptide compounds | 陕西麦科奥特科技有限公司 | 2023-09-26 | — | — | CN | disclosed |
| EP-4212542-A1 | BISPECIFIC FUSION POLYPEPTIDE COMPOUND | Shaanxi Micot Technology Limited Company (CN) | 2023-07-19 | — | — | EP | disclosed |
| CN-115087662-A | Bispecific fusion polypeptide compounds | 陕西麦科奥特科技有限公司 | 2022-09-20 | — | — | CN | disclosed |
| WO-2022052471-A1 | BISPECIFIC FUSION POLYPEPTIDE COMPOUND | 陕西麦科奥特科技有限公司 | 2022-03-17 | — | — | WO | disclosed |
| US-20160376579-A1 | NEW ENZYMES AND METHOD FOR PREPARING 4-HYDROXYL BENZYL ALCOHOL AND DERIVATIVES THEREOF | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2016-12-29 | — | — | US | disclosed |
| EP-3083972-A2 | NEW ENZYMES AND METHOD FOR PREPARING 4-HYDROXYL BENZYL ALCOHOL AND DERIVATIVES THEREOF | Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) | 2016-10-26 | — | — | EP | disclosed |
| WO-2015091755-A2 | NEW ENZYMES AND METHOD FOR PREPARING 4-HYDROXYL BENZYL ALCOHOL AND DERIVATIVES THEREOF | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2015-06-25 | — | — | WO | disclosed |
| EP-2886656-A1 | New enzyme and method for preparing 4-hydroxyl benzyl alcohol and derivatives thereof | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2015-06-24 | — | — | EP | disclosed |
| WO-2012025464-A1 | FLUORODEUTERIOMETHYL TYROSINE DERIVATIVES | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2012-03-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230331779-A1 | BISPECIFIC FUSION POLYPEPTIDE COMPOUND | CALCR, BID, CASR | TDP1 4853/4885NR1I2 2033/4885PTGS1 3213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.